Retrospective chart review.
We report the rate of postoperative infection at our institution following the use of irradiated allograft, nonirradiated allograft, or autograft for spinal fusion procedures.
Infection after a spinal fusion procedure is a devastating complication. It has not been defined whether spine bone graft preparation has any correlation with postoperative infection in spinal fusion procedures.
We retrospectively identified 1435 patients who underwent spine fusion procedures with a minimum 1-year follow-up. Irradiated allograft was used in 144 patients, nonirradiated allograft was used in 441 patients, and autograft was used in 850 patients. Postoperative spinal infection was based on documented positive spine cultures at the time of re-exploration for presumed infection. Infection rates were estimated using the method of Kaplan and Meier; estimates were calculated out to 1-year postsurgery, and rates were compared using log-rank tests.
No significant difference in the rate of surgical site infection at 1 year was observed after the use of irradiated allograft (1.7%), nonirradiated allograft (3.2%), or autograft (4.3%), P = 0.51.
There is no significant difference in the rate of infection following spine fusion using irradiated allograft, nonirradiated allograft, or autograft. The selection of bone graft to aid in spinal fusion should be based on the requirements of surgical technique and availability of the desired tissue and not on a perceived association with postoperative infection.
This is a retrospective study to define the incidence of postoperative infection after the use of irradiated allograft, nonirradiated allograft, and autograft in spinal fusions. One thousand four hundred thirty-five patients undergoing spinal fusion procedures with a minimum 1-year follow-up were identified. No significant difference (P = 0.51) in the rate of infection was observed between the 3 groups.
From the Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN.
Acknowledgment date: June 24, 2008. Revision date: March 27, 2009. Acceptance date: April 1, 2009.
The manuscript submitted does not contain information about medical device(s)/drug(s).
No funds were received in support of this work. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.
Institutional review board approval was obtained for this study.
Address correspondence and reprint requests to Mark M. Mikhael, MD, Mayo Clinic, 200 First St, SW, Rochester, MN 55905; E-mail: email@example.com